Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Edge Therapeutics, Inc. (NASDAQ: EDGE).

Full DD Report for EDGE

You must become a subscriber to view this report.


Recent News from (NASDAQ: EDGE)

Edge Therapeutics reports Q3 results
Edge Therapeutics (NASDAQ: EDGE ): Q3 GAAP EPS of -$0.14. More news on: Edge Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: November, 01 2018 07:51
Edge Therapeutics Reports Third Quarter 2018 Financial Results
BERKELEY HEIGHTS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE) today announced financial results for the quarter ended September 30, 2018. Third Quarter Financial Results Cash Position: Cash, cash equivalents and marketable securities as of Septemb...
Source: GlobeNewswire
Date: November, 01 2018 06:00
Edge Therapeutics beats by $0.12
Edge Therapeutics (NASDAQ: EDGE ): Q2 EPS of -$0.41 beats by $0.12 . More news on: Edge Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 01 2018 06:07
Edge Therapeutics Reports Second Quarter 2018 Financial Results
BERKELEY HEIGHTS, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE) today announced financial results for the quarter ended June 30, 2018. Second Quarter Financial Results Cash Position: Cash, cash equivalents and marketable securities as of J...
Source: GlobeNewswire
Date: August, 01 2018 06:00
Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Edge Therapeutics, Inc. (EDGE) and Encourages Investors to Contact the Firm
NEW YORK, July 16, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Edge Therapeutics, Inc. (NASDAQ:EDGE). On April 23, 2018, a complaint was filed alleging that Defendants failed to disclose: (1) that th...
Source: GlobeNewswire
Date: July, 16 2018 19:04
Free Technical Research on Edge Therapeutics and Three More Biotech Equities
Stock Research Monitor: CTMX, DVAX, and EDIT LONDON, UK / ACCESSWIRE / July 9, 2018 / If you want a free Stock Review on EDGE sign up now at www.wallstequities.com/registration . On Friday, July 6, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged ...
Source: ACCESSWIRE IA
Date: July, 09 2018 07:20
Robbins Arroyo LLP: Edge Therapeutics, Inc. (EDGE) Misled Shareholders According to Class Action
Shareholder rights law firm Robbins Arroyo LLP reminds shareholders that purchasers of Edge Therapeutics, Inc. (NasdaqGS: EDGE) have filed a class action complaint against the company's officers and directors for alleged violations of the Securities Exchange Act of 1934 between December 29...
Source: Business Wire
Date: July, 05 2018 19:14
Your Daily Pharma Scoop: FDA Approval For Array, Edge Zooms, Summit Nosedives
Stocks in News: ARRY, EDGE Array BioPharma gets FDA approval for melanoma combo treatment; shares halted Discussion : Array Biopharma’s ( ARRY ) combo treatment of encorafenib and binimetinib for patients with advanced melanoma associated with a BRAF mutation receives FDA appro...
Source: SeekingAlpha
Date: June, 29 2018 02:48
Premarket Gainers as of 9:05 am (6/28/2018)
GBR +150% . More news on: New Concept Energy, Inc., PEDEVCO Corp., SAExploration Holdings, Inc., Stocks on the move, Read more ...
Source: SeekingAlpha
Date: June, 28 2018 09:18
Edge Therapeutics +45.6% as it discloses study data, strategic update
Edge Therapeutics (NASDAQ: EDGE ) is up 45.6% after hours after posting an update on its Phase 3 NEWTON 2 study that also contained strategic news. More news on: Edge Therapeutics, Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: June, 27 2018 17:12

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-110.470.46050.50990.4561576,605
2018-12-100.500.4650.51990.45521,032
2018-12-070.47010.510.52470.4701495,872
2018-12-060.5320.5040.54980.4826663,874
2018-12-040.58820.54010.58820.531475,527

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1123,43061,62138.0228Short
2018-12-1048,683121,69840.0031Short
2018-12-0719,276180,00410.7087Cover
2018-12-0666,235231,04528.6676Cover
2018-12-0428,325125,06422.6484Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on EDGE.


About Edge Therapeutics, Inc. (NASDAQ: EDGE)

Logo for Edge Therapeutics, Inc. (NASDAQ: EDGE)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $31,246,231 - 05/15/2018
  • Issue and Outstanding: 31,246,231 - 04/25/2018

 


Recent Filings from (NASDAQ: EDGE)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 01 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 30 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 25 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 25 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: April, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 29 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: March, 02 2018

 

 


Daily Technical Chart for (NASDAQ: EDGE)

Daily Technical Chart for (NASDAQ: EDGE)


Stay tuned for daily updates and more on (NASDAQ: EDGE)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: EDGE)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in EDGE is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of EDGE and does not buy, sell, or trade any shares of EDGE. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/